Biogen AB Fuels Antifungal Growth: 54.7M SEK Valuation, 40M SEK Capital for BSG005
Biopharma breakthrough: Biosergen AB’s merger with Flerie and 40 M SEK funding boost accelerate BSG005 antifungal development, raising confidence and market reach.
2 minutes to read